Share on StockTwits

BTG plc (LON:BTG) has received a consensus recommendation of “Hold” from the ten ratings firms that are presently covering the stock, StockRatingsNetwork.com reports. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and six have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is GBX 566.25 ($9.50).

BTG plc (LON:BTG) opened at 613.50 on Wednesday. BTG plc has a one year low of GBX 363.00 and a one year high of GBX 665.00. The stock’s 50-day moving average is GBX 617.9 and its 200-day moving average is GBX 584.. The company’s market cap is £2.214 billion.

A number of research firms have recently commented on BTG. Analysts at Deutsche Bank reiterated a “buy” rating on shares of BTG plc in a research note on Tuesday, August 12th. They now have a GBX 655 ($10.99) price target on the stock. Separately, analysts at Jefferies Group upgraded shares of BTG plc to a “buy” rating in a research note on Tuesday, July 29th. They now have a GBX 760 ($12.75) price target on the stock, up previously from GBX 525 ($8.81).

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.